Predictive Oncology (POAI) said Thursday that it has developed two 3D liver toxicity models exclusively for Labcorp (LH).

The models simulate human and rat liver environments and can be used to evaluate and predict drug clearance, drug transport, and liver toxicity related to drugs, as well as provide insights into how cancer treatments might work in patients, according to the company.

Tests showed that the models were functional for up to 14 days, the company said.

Shares of Predictive Oncology were up 1.7%, while Labcorp was down 0.1% in recent trading.

Price: 1.00, Change: +0.02, Percent Change: +1.73